iShares Genomics Immunology and Healthcare ETF(IDNA)

POST42.170.000.00%19:30 EDT

42.17+1.75+4.33%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Moderna Has Surged 660% Year-To-Date, Joining The Nasdaq 100 As BofA Raises Its Price Target
  Reuters · 10:44
  Moderna Has Surged 660% Year-To-Date, Joining The Nasdaq 100 As BofA Raises Its Price Target
- Moderna Inc. Stock Advances 14.2%, Outperforms Peers
  Dow Jones · 04:32
  Moderna Inc. Stock Advances 14.2%, Outperforms Peers
- US Equity Markets End Higher Amid Broad Rally, Strong Mega-Cap Gains
  MT Newswires Live · 04:22
  US Equity Markets End Higher Amid Broad Rally, Strong Mega-Cap Gains
- S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT
  Reuters · 03:30
  S&P 500 Top and Bottom Performing Stocks at About 03:30 P.m. EDT
- Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why
  TIPRANKS · 02:12
  Moderna Stock (MRNA) Climbs 13% to Top Its 52-Week High — Here’s Why
- Moderna up over 11%, on Track for Highest Close Since January 2022
  Dow Jones · 01:30
  Moderna up over 11%, on Track for Highest Close Since January 2022
- Vertex Pharmaceuticals to present data on Alyftrek at NACFC
  TIPRANKS · 01:20
  Vertex Pharmaceuticals to present data on Alyftrek at NACFC
- Sector Update: Healthcare
  MT Newswires Live · 01:18
  Sector Update: Healthcare
- Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function
  Reuters · 01:15
  Vertex Says Interim Alyftrek Study Data Show Some CF Children Ages 2-5 Regain Pancreatic Function
- Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
  TIPRANKS · 00:31
  Incyte’s Latest Dermal PK Study: What Completed Early-Stage Data Mean for INCY Investors
- Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.
  Dow Jones · 00:31
  Flu Season is Already Here. Here's What to Know About This Year's Flu Shots.
- Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors
  TIPRANKS · 00:30
  Vertex and Moderna Advance CF mRNA Therapy: What VX-522 Trial Completion Means for Investors
- Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand
  MT Newswires Live · 00:14
  Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand
- Top Midday Gainers
  MT Newswires Live · 00:06
  Top Midday Gainers
- Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200
  TradingKey · 10-09 23:32
  Moderna Stock Surges Over 10% to Hit New Recent High: Melanoma Vaccine Data Set for ESMO, BofA Raises Price Target to $200
- NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09
  Reuters · 10-09 23:01
  NASDAQ Top and Bottom Performing Stocks at About 11:01 A.m. EDT on 2026-10-09
- Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines
  MT Newswires Live · 10-09 22:57
  Market Chatter: Moderna, Other Vaccine Developer Stocks Rise as NIH Plans to Expedite Cancer Vaccines
- NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump
  MT Newswires Live · 10-09 22:48
  NIH Plans to Expedite Cancer Vaccines, NYT Reports; Vaccine Developer Shares Jump
- BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating
  MT Newswires Live · 10-09 22:17
  BofA Securities Adjusts Price Target on Moderna to $200 From $170, Maintains Neutral Rating
- Moderna Inc Stock (MRNA) Moved Up by 7.63% on Oct 9: A Full Analysis
  TradingKey · 10-09 22:15
  Moderna Inc Stock (MRNA) Moved Up by 7.63% on Oct 9: A Full Analysis
Company Profile
Company Name
iShares Genomics Immunology and Healthcare ETF
Market
ARCA
Establishment Date
- -
Employees
- -
Office Location
- -
Website
- -
Zip Code
- -
Phone
- -
Fax
- -
Introduction
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

1D
5D
Day
Week
Month

Loading ...

High

42.27

Open

40.52

Volume%

0.88

Low

40.52

40.42

T/O Rate

2.03%

To The Moon

iShares Genomics Immunology and Healthcare ETF(IDNA)

Company Profile

Most Discussed